A Pediatric Asthma Risk Score to better predict asthma development in young children

Publication date: Available online 13 December 2018

Source: Journal of Allergy and Clinical Immunology

Author(s): Jocelyn M. Biagini Myers, Eric Schauberger, Hua He, Lisa J. Martin, John Kroner, Gregory M. Hill, Patrick H. Ryan, Grace K. LeMasters, David I. Bernstein, James E. Lockey, S. Hasan Arshad, Ramesh Kurukulaaratchy, Gurjit K. Khurana Hershey

Background

Asthma phenotypes are currently not amenable to primary prevention or early intervention because their natural history cannot be reliably predicted. Clinicians remain reliant on poorly predictive asthma outcome tools because of a lack of better alternatives.

Objective

We sought to develop a quantitative personalized tool to predict asthma development in young children.

Methods

Data from the Cincinnati Childhood Allergy and Air Pollution Study (n = 762) birth cohort were used to identify factors that predicted asthma development. The Pediatric Asthma Risk Score (PARS) was constructed by integrating demographic and clinical data. The sensitivity and specificity of PARS were compared with those of the Asthma Predictive Index (API) and replicated in the Isle of Wight birth cohort.

Results

PARS reliably predicted asthma development in the Cincinnati Childhood Allergy and Air Pollution Study (sensitivity = 0.68, specificity = 0.77). Although both the PARS and API predicted asthma in high-risk children, the PARS had improved ability to predict asthma in children with mild-to-moderate asthma risk. In addition to parental asthma, eczema, and wheezing apart from colds, variables that predicted asthma in the PARS included early wheezing (odds ratio [OR], 2.88; 95% CI, 1.52-5.37), sensitization to 2 or more food allergens and/or aeroallergens (OR, 2.44; 95% CI, 1.49-4.05), and African American race (OR, 2.04; 95% CI, 1.19-3.47). The PARS was replicated in the Isle of Wight birth cohort (sensitivity = 0.67, specificity = 0.79), demonstrating that it is a robust, valid, and generalizable asthma predictive tool.

Conclusions

The PARS performed better than the API in children with mild-to-moderate asthma. This is significant because these children are the most common and most difficult to predict and might be the most amenable to prevention strategies.

Graphical abstract

from Allergy and Immunology via a.sfakia on Inoreader https://ift.tt/2Gqzo9I